MMP2 and chronic kidney disease: In the study of Gluba-Brzózka A et al., CAD patients with CKD had significantly higher renalase, osteocalcin, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and lower fetuin-A than CAD patients without CKD [35].